Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
How Do Urologists Interpret Risk? Differences in Appropriateness of Active Surveillance Based on Clinical-Based vs Probability-Based Risk Assessments.
Journal: Urology practice
Published: June 02, 2025
Utilization and Cancer Control Outcomes of Active Surveillance Amongst Black and White Men with Intermediate Risk Prostate Cancer in a Population-Based Analysis.
Journal: Journal of racial and ethnic health disparities
Published: October 07, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohort.
Journal: JNCI cancer spectrum
Published: September 11, 2024
The Role of Cytoreductive Nephrectomy in Contemporary Metastatic Renal Cell Carcinoma: An Other-Cause Mortality Match Population-Based Study.
Journal: Clinical genitourinary cancer
Published: September 08, 2024
Prostate Cancer Screening and Diagnoses in the Transfeminine Population.
Journal: Urology
Published: September 03, 2024
Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.
Journal: International urology and nephrology
Published: June 10, 2024
The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014.
Journal: World journal of urology
Published: May 28, 2024
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
Journal: The Prostate
Published: May 14, 2024
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort.
Journal: European urology oncology
Published: March 18, 2024
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Journal: Cancer
Published: January 17, 2024
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort.
Journal: Urologic oncology
Published: September 07, 2023
Last Updated: 09/26/2026